<p><b>A.</b> Dynamics of c-Abl phosphorylation in BA/A-treated cells. SK-GT-4 cells were treated with 100 µM BA cocktail, pH 4.0. Extracts were collected at the indicated time and analyzed by Western blotting. Early (5–30 minutes) and late (4–24 hours) time points are shown. <b>B.</b> Western blot analysis for phospho-ΔNp73(Y50) in SK-GT-4 cells stably transfected with ΔNp73α. Cells were collected at indicated time after treatment with BA/A (100 µM, 30 min). <b>C.</b> c-Abl chemical inhibitor Imatinib downregulates the ΔNp73 protein. SK-GT-4 cells were pretreated with Imatinib (30 µM) for 1 hour, treated with BA/A (100 µM) for 30 minutes and then incubated for an additional 7 hours in the presence of the indicated inhibitor. Total cell extr...
<p>(A). Lysates of Neuro2A cells stably transfected with c-Abl RNAi #1 or #2 or the control vector w...
Chronic myeloid leukemia (CML) is characterized by the presence of the constitutively active BCR-ABL...
Bcr-Abl is a constitutively active tyrosine kinase involved in the development and progression of ch...
<p><b>A.</b> Dynamics of IKKα/β phosphorylation in BA/A-treated cells. SK-GT-4 cells were treated wi...
<p><b>A.</b> Dynamics of p38 protein phosphorylation in BA/A-treated cells. SK-GT-4 cells were treat...
<p>(A) HeLa and CaSki Cells were transfected with non-targeting or c-Abl siRNA (75 nM). Western blot...
Chronic Myeloid Leukemia (CML) is a disease of hematopoietic stem cells which harbor the chimeric ge...
<p>For each recombinant kinase, bar charts of the mean values of the triplicate activity raw counts ...
The BCR/ABL fusion protein transforms myeloid stem cells. Both chronic myelogenous leukemias (CML) a...
<p>K562 cells were treated with increasing concentrations of tyrosine kinase inhibitors. Untreated c...
Background: Deregulated c-Abl activity has been intensively studied in a variety of solid tumors and...
<p>(<b>A</b>) Western blot analysis showed that BA treatment lowered the protein levels of cyclins, ...
<p>(<b>A</b>) Assessment of Abl kinase activation, as determined by phospho-CrkL tyrosine (Y) 207 le...
AbstractC-Abl is a nonreceptor tyrosine kinase that is tightly regulated in the cell. Genetic data d...
<p>(<b>A</b>) Cells were treated with imatinib (72 h), washed, treated with doxorubicin (30′) in the...
<p>(A). Lysates of Neuro2A cells stably transfected with c-Abl RNAi #1 or #2 or the control vector w...
Chronic myeloid leukemia (CML) is characterized by the presence of the constitutively active BCR-ABL...
Bcr-Abl is a constitutively active tyrosine kinase involved in the development and progression of ch...
<p><b>A.</b> Dynamics of IKKα/β phosphorylation in BA/A-treated cells. SK-GT-4 cells were treated wi...
<p><b>A.</b> Dynamics of p38 protein phosphorylation in BA/A-treated cells. SK-GT-4 cells were treat...
<p>(A) HeLa and CaSki Cells were transfected with non-targeting or c-Abl siRNA (75 nM). Western blot...
Chronic Myeloid Leukemia (CML) is a disease of hematopoietic stem cells which harbor the chimeric ge...
<p>For each recombinant kinase, bar charts of the mean values of the triplicate activity raw counts ...
The BCR/ABL fusion protein transforms myeloid stem cells. Both chronic myelogenous leukemias (CML) a...
<p>K562 cells were treated with increasing concentrations of tyrosine kinase inhibitors. Untreated c...
Background: Deregulated c-Abl activity has been intensively studied in a variety of solid tumors and...
<p>(<b>A</b>) Western blot analysis showed that BA treatment lowered the protein levels of cyclins, ...
<p>(<b>A</b>) Assessment of Abl kinase activation, as determined by phospho-CrkL tyrosine (Y) 207 le...
AbstractC-Abl is a nonreceptor tyrosine kinase that is tightly regulated in the cell. Genetic data d...
<p>(<b>A</b>) Cells were treated with imatinib (72 h), washed, treated with doxorubicin (30′) in the...
<p>(A). Lysates of Neuro2A cells stably transfected with c-Abl RNAi #1 or #2 or the control vector w...
Chronic myeloid leukemia (CML) is characterized by the presence of the constitutively active BCR-ABL...
Bcr-Abl is a constitutively active tyrosine kinase involved in the development and progression of ch...